By Business/Source
Currency:SGD
2025/FY
Stock NameRevenueRatio
Specialty Pharmaceutical7.07M91.03%
Nutraceutical1.11M14.32%
Inter-segment sales-415K-5.34%
By Country/Region
Currency:SGD
2024/FY
Stock NameRevenueRatio
Australia5.47M91.71%
China408K6.85%
Singapore and Others81K1.36%
United States of America5K0.08%
